✦ LIBER ✦

GPR35 as a Novel Therapeutic Target

✍ Scribed by MacKenzie, A. E.; Lappin, J. E.; Taylor, D. L.; Nicklin, S. A.; Milligan, G.

Book ID: 115469057
Publisher: Frontiers
Year: 2011
Tongue: English
Weight: 567 KB
Volume: 2
Category: Article
ISSN: 1664-2392
DOI: 10.3389/fendo.2011.00068

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

GPR30: a novel therapeutic target in est

GPR30: a novel therapeutic target in estrogen-related disease

✍ Eric R. Prossnitz; Larry A. Sklar; Tudor I. Oprea; Jeffrey B. Arterburn 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 597 KB

Nuclear EGFR as Novel Therapeutic Target

✍ Klaus Dittmann; Claus Mayer; H. Peter Rodemann 📂 Article 📅 2009 🏛 Springer 🌐 German ⚖ 278 KB

GPR35 is a novel lysophosphatidic acid r

GPR35 is a novel lysophosphatidic acid receptor

✍ Saori Oka; Ryo Ota; Mitsuru Shima; Atsushi Yamashita; Takayuki Sugiura 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 466 KB

Free fatty acid receptors FFAR1 and GPR1

Free fatty acid receptors FFAR1 and GPR120 as novel therapeutic targets for metabolic disorders

✍ Takafumi Hara; Akira Hirasawa; Atsuhiko Ichimura; Ikuo Kimura; Gozoh Tsujimoto 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB

Free fatty acids (FFAs) are not only essential nutritional components, but they also act as signaling molecules in various physiological processes. Recently, a G-protein-coupled receptor deorphanizing strategy has successfully identified a family of receptors that are activated by FFAs. FFA receptor

Targeting melanocortin receptors as pote

Targeting melanocortin receptors as potential novel therapeutics

✍ Stephen J. Getting 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 315 KB

Angiogenesis as a therapeutic target

✍ Ferrara, Napoleone; Kerbel, Robert S. 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 451 KB